234: For Patients With Hypophosphatasia (HPP): One Enzyme, A World of Potential

Industry Presenter(s)

• 

  Alvin Wells, MD, PhD, FACR

  Director
  Rheumatology and Immunotherapy Center
  Franklin, Wisconsin, United States

  Disclosure information not submitted.

Developed & offered by Alexion, AstraZeneca Rare Disease